ArticleCureus2025
Triple Threat: Co-occurrence of Serous Borderline Ovarian Tumor, Endometrial Adenocarcinoma, and Low-Grade Appendiceal Mucinous Neoplasms With Pseudomyxoma Peritonei in a Single Patient.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Borderline ovarian tumors (BOTs) are epithelial ovarian neoplasms characterized by cellular proliferation and nuclear atypia without stromal invasion. On the other hand, low-grade appendiceal mucinous neoplasms (LAMNs) have features such as mucin production, a distinct invasion pattern, and low-grade cytological characteristics. Pseudomyxoma peritonei (PMP), an uncommon disorder characterized by mucinous peritoneal dispersion, can be exacerbated by both BOTs and LAMNs. We present a case of a 63-year-old patient who was diagnosed with a serous BOT, LAMN with PMP, and synchronous endometrioid endometrial cancer. After episodes of postmenopausal bleeding, an explorative curettage confirmed the diagnosis of endometrioid endometrial cancer. Since the preoperative ultrasound showed a tumorous mass in the right adnexa and retrouterine space, the patient had an explorative laparotomy. A right ovarian tumor, hepatic and omental deposits, and an appendiceal lesion were among the intraoperative findings. A hysterectomy was performed along with peritoneal biopsy, cytological analysis of peritoneal lavage, bilateral salpingo-oophorectomy, omentectomy, lymphadenectomy, and appendectomy. Histopathological examination verified the presence of BOT, LAMN with PMP, and endometrial cancer. This case highlights the diagnostic difficulties of synchronous gastrointestinal and gynecological neoplasms and emphasizes the significance of a multidisciplinary surgical approach and thorough preoperative examination. According to our knowledge, this is the first case of synchronous endometrial cancer, serous BOT, and LAMN with PMP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.